Ultragenyx Pharmaceutical
RARE
RARE
190 hedge funds and large institutions have $4.94B invested in Ultragenyx Pharmaceutical in 2020 Q2 according to their latest regulatory filings, with 33 funds opening new positions, 65 increasing their positions, 66 reducing their positions, and 14 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more capital invested
Capital invested by funds: $ → $
more call options, than puts
Call options by funds: $ | Put options by funds: $
more funds holding
Funds holding: →
1.79% more ownership
Funds ownership: 103.99% → 105.79% (+1.8%)
2% less repeat investments, than reductions
Existing positions increased: 65 | Existing positions reduced: 66
100% less funds holding in top 10
Funds holding in top 10: 1 → 0 (-1)
Holders
190
Holding in Top 10
–
Calls
$21M
Puts
$14.1M
Top Buyers
| 1 | +$231M | |
| 2 | +$42M | |
| 3 | +$27.2M | |
| 4 |
EAM
Eagle Asset Management
St Petersburg,
Florida
|
+$20.3M |
| 5 |
First Trust Advisors
Wheaton,
Illinois
|
+$17.6M |
Top Sellers
| 1 | -$75.9M | |
| 2 | -$26.1M | |
| 3 | -$19.6M | |
| 4 |
Wellington Management Group
Boston,
Massachusetts
|
-$17.4M |
| 5 |
Barclays
London,
United Kingdom
|
-$9.17M |